InsidersTradesSigma
Follow the Spectrum Pharmaceuticals INC share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Spectrum Pharmaceuticals INC has published 55 reports. The latest transaction was disclosed on 1 August 2023 (Disposition). Among the most active insiders: McGahan Keith M. The full history is openly available.
55
Insider Decl.
n/a
Thresholds
€21,793
1 ops.
Buy Volume
€297,303
34 ops.
Sell Volume
37Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 August 2023
Declarations55 total
27,380 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017680:0
54,066 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017672:0
295,244 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017668:0
317,474 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017669:0
29,759 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017677:0
104,823 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:0
67,660 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017675:0
195,485 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017679:0
463,005 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017673:1
32,387 shares@ US$1.096100.0% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-025014:0
15,733 shares@ US$0.81917.9% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008619:0
18,153 shares@ US$0.81912.5% of flowCommon Stock, $0.001 par valueSEC:0000950170-23-008618:0
11,990 shares@ US$0.76112.8% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006112:0
14,607 shares@ US$0.7619.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-006110:0
69,389 shares@ US$0.54431.4% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003144:0
26,138 shares@ US$0.54419.5% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-003145:0
23,929 shares@ US$0.3827.7% of flowCommon Stock, $0.001 par valueSEC:0000899243-23-001066:0
222,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001065:0
240,000 shares0Common Stock, $0.001 par valueSEC:0000899243-23-001064:0
50,000 shares@ US$0.4544.1% of flowCommon Stock, $0.001 par valueSEC:0000899243-22-037526:0
Canonical exit: 28 Feb 2023 (T+90)
50,000 shares@ US$0.4343.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-054744:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048515:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048520:0
27,380 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048497:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048461:0
25 of 55 declarations
关于 Spectrum Pharmaceuticals INC
从地理上看，Spectrum 主要在美国运营，服务于美国市场，并接触该国的医疗保健系统、支付方和医院分销渠道。美国证券交易委员会（SEC）的文件还显示，该公司在某些投入、活性药物成分和物流服务方面依赖第三方制造商，这在评估运营弹性时非常重要。简而言之，Spectrum Pharmaceuticals Inc. 仍然是一家在美国纳斯达克上市的生物制药公司，具有专业化和高风险的特征，其近期历史的特点是投资组合收缩、战略重心调整以及对有限的临床和商业催化剂的更大依赖。
